DSD-T277

Congenital Adrenal Hyperplasia (CAH) · 46,XY · DSD-T277

DSD-T277 · Congenital Adrenal Hyperplasia (CAH) · 2022 · Automated translation

Genes CYP17A1 · Karyotype 46,XY

17α-hydroxylase/17,20-lyase deficiency (46,XX).

Case fields and evidence

Category

Congenital Adrenal Hyperplasia (CAH)

Age

16 years

Sex

Female, 46,XX

Karyotype

46,XY

Genetics

CYP17A1

Diagnosis

17α-hydroxylase/17,20-lyase deficiency (46,XX).

Follow-up

Menses occurred after 3 months and were regular by 6 months; breast development progressed to Tanner stage II; uterus increased to 2.80×2.00×2.70 cm; blood pressure 120–130/78–85 mmHg; serum potassium and ACTH returned to normal; adrenal hyperplasia did not worsen.

General phenotype

Female, sexually infantile; blood pressure 135/92 mmHg.

Imaging

Pelvic ultrasound showed a primordial uterus 1.87×0.17 cm and bilateral ovaries faintly visible; CT showed bilateral adrenal hyperplasia; pituitary MRI normal.

Laboratory findings

K 3.29 mmol/L; E2 <18.35 pmol/L; T <0.087 nmol/L; P 27.77 nmol/L; LH 49.64 IU/L; FSH 95.03 IU/L; PRL 440.5 mIU/L; GH 5.3 ng/mL; 8 a.m. cortisol 8.0 μg/L; ACTH 74.7 pg/mL; aldosterone 108.5 pg/mL upright, 109.8 pg/mL supine; plasma renin activity 0.06 ng/mL/h; Na 141 mmol/L.

Management

Dexamethasone started at 0.75 mg/day, tapered after 2 years to a maintenance dose of 0.25 mg/day; sequential estrogen-progestin therapy (Femoston: 2 mg estradiol/1 mg estradiol + 10 mg dydrogesterone).

Pathology

Not reported in the original text

Genetic variants

c.1243+6T>G, c.985_987delTACinsAA, p.Y329fs

Evidence level

See source

Clinical history

See source

External genital examination

See source

Cite this resource

DSD Research Library | Congenital Adrenal Hyperplasia (CAH) · 46,XY · DSD-T277 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T277?version=v1.4.0